fenofibric acid has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslanidis, C; Bollheimer, C; Buechler, C; Büttner, R; Neumeier, M; Schäffler, A; Schmidl, C; Schölmerich, J; Weigert, J; Weiss, TS | 1 |
| Chew, GT; Sahebkar, A; Watts, GF | 1 |
1 review(s) available for fenofibric acid and Liver Steatosis
| Article | Year |
|---|---|
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides | 2014 |
1 other study(ies) available for fenofibric acid and Liver Steatosis
| Article | Year |
|---|---|
Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro.
Topics: Adiponectin; Aldehyde Oxidoreductases; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Fatty Liver; Fenofibrate; Hepatocytes; Humans; Rats; Rats, Wistar | 2006 |